A1D5U

Dexmethylphenidate

Created:2024-01-31
Last modified:  2025-08-25

Find related ligands:

Chemical Details

Formal Charge0
Atom Count36
Chiral Atom Count2
Bond Count37
Aromatic Bond Count6
2D diagram of A1D5U

Chemical Component Summary

NameDexmethylphenidate
Systematic Name (OpenEye OEToolkits)methyl (2~{R})-2-phenyl-2-[(2~{R})-piperidin-2-yl]ethanoate
FormulaC14 H19 N O2
Molecular Weight233.306
TypeNON-POLYMER

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESCACTVS3.385COC(=O)[CH]([CH]1CCCCN1)c2ccccc2
SMILESOpenEye OEToolkits2.0.7COC(=O)C(c1ccccc1)C2CCCCN2
Canonical SMILESCACTVS3.385 COC(=O)[C@@H]([C@H]1CCCCN1)c2ccccc2
Canonical SMILESOpenEye OEToolkits2.0.7 COC(=O)[C@H](c1ccccc1)[C@H]2CCCCN2
InChIInChI1.06 InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3/t12-,13-/m1/s1
InChIKeyInChI1.06 DUGOZIWVEXMGBE-CHWSQXEVSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
DrugBank IDDB06701 
NameDexmethylphenidate
Groups
  • approved
  • investigational
DescriptionDexmethylphenidate is the dextrorotary form of methylphenidate introduced in 2002[A177181]. It is a norepinephrine-dopamine reuptake inhibitor (NDRI) and thus a psychostimulant[A177193]. It is used for treatment of Attention Deficit Hyperactivity Disorder (ADHD)[Label,A177181]. The d-isomer is thought to have greater effect with fewer side effects than the l-isomer or the racemic mixture[A177181].
Synonyms
  • d-threo-methylphenidate
  • Dexmethylphenidatum
  • methyl (R)-phenyl[(R)-piperidin-2-yl]acetate
  • D-TMP
  • Dexméthylphénidate
Brand Names
  • FocalinXR
  • Dexmethylphenidate HCl
  • Dexmethylphenidate Hydrochloride Extended-Release
  • Focalin
  • Attenade
IndicationDexmethylphenidate is used as a treatment for ADHD, ideally in conjunction with psychological, educational, behavioral or other forms of treatment[A177187,Label].
Categories
  • Agents that produce hypertension
  • Antidepressive Agents
  • Central Nervous System Agents
  • Central Nervous System Depressants
  • Central Nervous System Stimulants
ATC-Code
  • N06BA11
  • N06BA15
CAS number40431-64-9

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
NameTarget SequencePharmacological ActionActions
Sodium-dependent dopamine transporterMSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNP...unknowninhibitor
Sodium-dependent noradrenaline transporterMLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRD...unknowninhibitor
Sodium-dependent serotonin transporterMETTPLNSQKQLSACEDGEDCQENGVLQKVVPTPGDKVESGQISNGYSAV...unknowninhibitor
Carboxylesterase

MWLRAFILATLSASAAW

unknownsubstrate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL827
PubChem 154101
ChEMBL CHEMBL827
ChEBI CHEBI:51860
CCDC/CSD YEGVIS